HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Graffagnino Selected Research

lotrafiban

8/2000Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic disease.
6/2000Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Graffagnino Research Topics

Disease

3Stroke (Strokes)
02/2003 - 06/2000
2Thrombocytopenia (Thrombopenia)
09/2001 - 08/2000
1Brain Injuries (Brain Injury)
11/2012
1Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
04/2009
1Bradycardia
09/2001
1Pneumonia (Pneumonitis)
09/2001
1Hypothermia
09/2001
1Cardiovascular Diseases (Cardiovascular Disease)
08/2000
1Hemorrhage
08/2000
1Atherosclerosis
08/2000
1Transient Ischemic Attack
06/2000
1Unstable Angina
06/2000
1Vascular Diseases (Vascular Disease)
06/2000
1Ischemic Stroke
06/2000
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
06/2000
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
06/2000
1Myocardial Infarction
06/2000

Drug/Important Bio-Agent (IBA)

2lotrafibanIBA
08/2000 - 06/2000
1Propofol (Diprivan)FDA LinkGeneric
11/2012
1DexmedetomidineFDA Link
11/2012
1Apolipoproteins E (ApoE)IBA
02/2003
1IceIBA
09/2001
1Pharmaceutical PreparationsIBA
08/2000
1Platelet Membrane GlycoproteinsIBA
08/2000
1tetrachloroisophthalonitrile (Bravo)IBA
06/2000
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
06/2000
1Adenosine Diphosphate (ADP)IBA
06/2000
1Ticlopidine (Ticlid)FDA LinkGeneric
06/2000
1Clopidogrel (Plavix)FDA Link
06/2000
1thienopyridineIBA
06/2000

Therapy/Procedure

2Therapeutics
09/2001 - 06/2000
1Length of Stay
04/2009
1Secondary Prevention
08/2000